N/A
N=2,713
COmmuNity-engaged SimULation Training for Blood Pressure Control
Hypertension
Bottom Line
View on ClinicalTrials.gov: NCT03375918 ↗Enrolled (actual)
2,713
Serious AEs
0.0%
Results posted
Sep 2025
Primary outcome: Primary: Blood Pressure — 137.6; 136.4; 82.1; 81.8 mm Hg
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- CONSULT-BP Educational Intervention (Other)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- University of Massachusetts, Worcester
- Primary completion
- Dec 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Blood Pressure |
137.6; 136.4; 82.1; 81.8 | — |
| SECONDARY RELATE Checklist, a Standardized Patient Rating Scale for Bias-Mitigating and Patient-Centered Communication |
32.7 | — |
Summary
The goal of CONSULT-BP is to train early-stage healthcare providers, including residents and nurse practitioner (NP) students, to mitigate providers' bias, improve communication skills, and enhance providers' ability to develop authentic and meaningful therapeutic alliances with patients. The study setting is an academic safety net hospital that serves a large non-White and poor population. The Investigators hypothesize that patients' outcomes (blood pressure levels) will be lower after the training intervention compared with before training (control) periods.
Eligibility Criteria
For Healthcare Trainees -
Inclusion Criteria
- Practice at a clinical site supported by an EMR to allow clinical data collection for outcome measurement
- 15-week clinical look-back period
- No prior completion of the CONSULT-BP intervention
Exclusion Criteria: 1. All 1st year trainees
For Patient Participants -
Inclusion Criteria
- English-speaking
- Non-White racial/ethnic minority or Medicaid recipient (regardless of race/ethnicity)
- Hypertension identified in the EMR
Exclusion Criteria
- Enrolled in hospice.
- Pregnancy, dementia, schizophrenia, bipolar illness, or other serious medical co-morbidity that would interfere with hypertension self-control
Data sourced from ClinicalTrials.gov (NCT03375918). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.